EXPE
67
3
XRAY
10
-3
CSX
39
2
WAT
44
2
WU
32
2
CF
38
3
CFG
50
4
DRI
69
6
CAT
42
3
PWR
47
3
CSCO
56
3
RSG
76
5
CRM
34
4
NFLX
64
2
K
69
3
BRK.B
49
6
BLK
61
18
NEM
34
6
UNP
36
-3
HRL
41
11
EXPE
67
3
XRAY
10
-3
CSX
39
2
WAT
44
2
WU
32
2
CF
38
3
CFG
50
4
DRI
69
6
CAT
42
3
PWR
47
3
CSCO
56
3
RSG
76
5
CRM
34
4
NFLX
64
2
K
69
3
BRK.B
49
6
BLK
61
18
NEM
34
6
UNP
36
-3
HRL
41
11
Financhill
Back

Greenlight Capital Re Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
62

GLRE
Greenlight Capital Re

Last Price:
$13.92
Seasonality Move:
-0.66%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$106.83
Seasonality Move:
8.04%
Buy
62
Greenlight Capital Re (GLRE) is a Buy

Is Greenlight Capital Re a Buy, Sell or Hold?

  • The current Greenlight Capital Re [GLRE] share price is $13.93. The Score for GLRE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

  • The Greenlight Capital Re share price today is $13.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $106.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 57.74 Buy
Chaikin Money Flow: 94951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.32 - 13.78) Buy
Bollinger Bands (100): (13.42 - 14.58) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.25 Sell
Relative Strength Index (14 RSI): 41.97 Sell
Chaikin Money Flow: 469170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.93 - 115.87) Sell
Bollinger Bands (100): (111.92 - 127.28) Sell

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.53 Buy
20-day SMA: 13.5 Buy
50-day SMA: 13.75 Buy
200-day SMA: 13.62 Buy
8-day EMA: 13.61 Buy
20-day EMA: 13.58 Buy
50-day EMA: 13.75 Buy
200-day EMA: 13.46 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.35 Buy
20-day SMA: 109.97 Sell
50-day SMA: 116.57 Sell
200-day SMA: 127.54 Sell
8-day EMA: 106.76 Buy
20-day EMA: 109.7 Sell
50-day EMA: 114.67 Sell
200-day EMA: 122.08 Sell

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.

Greenlight Capital Re Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):